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Abstract
Background: Proliferative vitreoretinopathy (PVR) is a destructive complication of retinal detachment and vitreoretinal
surgery which can lead to severe vision reduction by tractional retinal detachments. The purpose of this study was to
determine the gene expression profile of epiretinal membranes (ERMs) associated with a PVR (PVR-ERM) and to compare it
to the expression profile of less-aggressive secondary ERMs.
Methodology/Principal Findings: A PCR-amplified complementary DNA (cDNA) library was constructed using the RNAs
isolated from ERMs obtained during vitrectomy. The sequence from the 59 end was obtained for randomly selected clones
and used to generate expressed sequence tags (ESTs). We obtained 1116 nonredundant clusters representing individual
genes expressed in PVR-ERMs, and 799 clusters representing the genes expressed in secondary ERMs. The transcriptome of
the PVR-ERMs was subdivided by functional subsets of genes related to metabolism, cell adhesion, cytoskeleton, signaling,
and other functions, by FatiGo analysis. The genes highly expressed in PVR-ERMs were compared to those expressed in the
secondary ERMs, and these were subdivided by cell adhesion, proliferation, and other functions. Querying 10 cell adhesion-
related genes against the STRING database yielded 70 possible physical relationships to other genes/proteins, which
included an additional 60 genes that were not detected in the PVR-ERM library. Of these, soluble CD44 and soluble vascular
cellular adhesion molecule-1 were significantly increased in the vitreous of patients with PVR.
Conclusions/Significance: Our results support an earlier hypothesis that a PVR-ERM, even from genomic points of view, is
an aberrant form of wound healing response. Genes preferentially expressed in PVR-ERMs may play an important role in the
progression of PVR and could be served as therapeutic targets.
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Introduction
Proliferative vitreoretinopathy (PVR) is a destructive complica-
tion of retinal detachment and vitreoretinal surgeries [1]. PVR is
believed to represent a maladapted retinal wound repair process
with proliferation of retinal and immune cells leading to the
formation of scar-like fibrous epiretinal membranes (ERMs) which
can cause tractional retinal detachment (RD).
At present, surgical removal of the fibrous membranes and
restoration of the physiological conditions are the first choice
treatments of PVR. Although the success rates of RD surgery was
significantly improved by vitrectomy combined with C3F8 gas or
silicone tamponade, the surgical treatment of PVR is often
unsuccessful. Therefore, the surgery needs to be supplemented by
local medications to inhibit the formation of new proliferative
lesions. Thus far, adjuvant treatments such as daunorubicin [2],
liposomal doxorubicin [3], and a combination of 5-fluorouracil
and low-molecular weight heparin [4] have been used to try to
prevent the development of PVR. Unfortunately, there is no
satisfactory anti-proliferative treatment available. Therefore, it is
important to develop new molecular targeting therapies based on
the exact pathogenesis of PVR.
The development of PVR is a complex process involving
humoral and cellular factors. The results of earlier studies showed
that the cells that are crucial for the formation of PVR-ERMs are
retinal pigment epithelial cells, glial cells, fibroblasts, and
macrophages [5]. In addition, various factors, including trans-
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forming growth factor-b2 (TGF-b2) [6], basic fibroblast growth
factor (bFGF) [7], platelet-derived growth factor (PDGF) [8],
tumor necrosis factor-a (TNF-a) [9], and monocyte chemotactic
protein-1 (MCP-1) [10] have been shown to be involved in the
pathogenesis of PVR.
Earlier conventional studies investigating the molecular factors
associated with PVR have focused mainly on one or a few
molecules or pathways. Therefore, a comprehensive examination
of the molecular events taking place in PVR that may lead to
epiretinal proliferation remains undetermined. Recent technolog-
ical advancements in genomics have given investigators new
opportunities to identify global gene expression in specific tissues
[11]. Expressed sequence tag (EST) analysis permit the identifi-
cation of genes expressed in individual tissues in a completely
unambiguous manner. Thus far, several eye-related EST projects
have been published utilizing whole human eyes, retinas, retinal
pigment epithelial cells, ciliary body, trabecular meshwork, corneal
epithelium, canine retinas, and mouse retinas [12]. However, an
EST analysis has not been performed on human ERM associated
with PVR (PVR-ERM) partly because of the difficulty in obtaining
sufficient amounts of human ERMs.
We have succeeded in performing EST analyses of the genes
expressed in epiretinal fibrovascular membranes (FVMs) from
patients with proliferative diabetic retinopathy [13–15]. We found
that unrecognized genes such as tumor endothelial cell marker 7
and periostin were highly expressed in FVMs. This indicated that
a comprehensive analysis of gene expression in ERMs may be an
important first step in enhancing our understanding of the
formation of ERM.
Secondary ERMs form on the inner surface of the macula in
eyes after intraocular surgery, e.g., after lensectomy, retinal
detachment surgery, and retinal laser photocoagulation [16].
Due to the wrinkling of the retina, an ERM can cause significant
distortions in the vision, i.e., metamorphopsias. However, the
progression of a secondary ERM is generally less aggressive and
seldom causes traction retinal detachment as do primary ERMs.
Biological events are associated with changes in the expression
of crucial genes. During the onset and progression of diseases,
extensive changes take place in gene expression [17]. By
comparing gene expression profiles under different conditions,
individual genes or group of genes that play important roles in a
particular disease process can be identified.
Thus, the purpose of this study was to determine the gene
expression profile of human PVR-ERMs and secondary ERMs,
and to compare genes differentially expressed between PVR-
ERMs and secondary ERMs. We hypothesized that this strategy
would identify differentially expressed genes that might be
responsible for the more aggressive behavior of PVR-ERMs.
Such studies may also provide new therapeutic agents that can be
targeted and thus inhibit the progression of PVR-ERMs.
Materials and Methods
Subjects
Procedures using human samples were conducted in accordance
with the Declaration of Helsinki and approved by the Kyushu
University Institutional Review Board for Clinical Research. We
obtained written informed consent from all the participants.
ERMs were surgically removed from 3 eyes of patients with
PVR and 2 eyes with a secondary ERM that developed after
cataract surgery. The ERMs were collected during pars plana
vitrectomy with membrane peeling. The ERM specimens
obtained from the 3 eyes with PVR (PVR-ERM; 62, 66, and 66
years) were processed for cDNA library construction. We also
collected vitreous samples from 11 eyes of 11 patients (age,
59.369.4 years; men:women, 7:4) with PVR during pars plana
vitrectomy. For control, vitreous samples were collected from 26
eyes of 26 patients (age 69.8610.2 years; men:women, 11:15) who
were undergoing ERM surgery.
RNA Extraction
All of the resected tissues were snap frozen and stored at
280uC. To prepare total RNA, the tissue was homogenized with a
MagNA Lyser Green Beads kit (Roche Applied Science,
Mannheim, Germany) according to the manufacturer’s instruc-
tions. Total RNA was extracted with TRizol (Qiagen, German-
town, MD) and exposed to DNase (RNase-free DNase set, Qiagen)
to eliminate potential genomic DNA contamination.
cDNA Synthesis
To overcome the limitation of the starting amounts of RNA,
SMARTTM (Switching Mechanism at the 59 end of RNA
Transcript) technology, an exponential PCR-based method, was
employed as described in detail [18]. Briefly, the total RNA was
reverse-transcribed using the SMART cDNA Library Construc-
tion Kit (Clontech, Palo Alto, CA) according to the manufacturer’s
protocol. Annealing was done at 70uC for 2 minutes in the
presence of the SMART oligosequence; (AAGCAGTGGTAT-
CAACGCAGAGTGGCCATTACGGCCGGG), and the over-
hang of the oligo(dT) primer (ATTCTAGAGGCC-
GAGGCGGCCGACATG [dT]30VN). The reaction was
followed by the addition of Superscript reverse transcriptase
(RT; Gibco-BRL, Gaithersburg, MD), and the mixture was
incubated at 37uC for 1 hour (final volume, 20 ml).
Representative double-stranded cDNAs were then generated by
exponential PCR amplification. Two microliters of each cDNA
fraction was amplified in a 100 ml reaction containing a final
concentration of 16 PCR reaction buffer (Advantage 2 PCR kit
(BD Biosciences Clontech)), 0.2 mM dNTPs, 0.5 pmol/ ml
forward primer (AAGCAGTGGTATCAACGCAGAGT),
0.5 pmol/ ml reverse primer (ATTCTAGAGGCC-
GAGGCGGCCGACATG), and 10 U/ ml Advantage 2 enzyme
mix (Clontech). The number of cycles needed for exponential
phase amplification of this cDNA was determined by running a
series of 10 ml analytical PCR amplifications at 18, 20, and 22
cycles using the same kit. We chose 20 cycles for the library
construction.
Size Fractionation of cDNA and Library Construction
To prevent an over representation of clones with short inserts,
the resultant cDNAs were size-fractionated using agarose gel
electrophoresis. For this, a PCR-amplified sample was loaded into
a single well of a 2% low-melting agarose gel. Three separate slices
corresponding to approximate molecular weights of 0.5 to 1 kb, 1
to 2 kb, and more than 2 kb were cut from the gel and melted at
65uC for 10 minutes [18]. cDNA was extracted from the gel slices
with agarase (Gelase, Epicentre, Madison, WI) according to the
manufacturer’s instructions. One-tenth of each eluted cDNA was
used for ligation into a cloning vector, pCR4-TOPO (Invitrogen,
Carlsbad, CA), according to the manufacturer’s protocol [19].
This was followed by transformation of Escherichia coli competent
cells (MAX Efficiency DH5a Chemically Competent Cells
(Invitrogen) and plated onto ampicillin-agar plates.
Sequence Analysis and Functional Annotation
Approximately the same number of colonies was randomly
selected for DNA sequencing. The colonies were inoculated into
Genes Highly Expressed in PVR
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individual wells of 96-well plates containing 150 mL of LB media,
and incubated at 37uC for 18–22 h. Frozen glycerol stocks were
prepared by adding 75 mL of 50% glycerol to each well, and the
plates were stored at 280uC. Double-stranded cDNAs were
obtained for sequencing either by miniprep (Invitrogen) or by
PCR amplification directly from frozen glycerol stocks as
described [20]. DNA sequencing from the 59 end of the cDNA
insert was carried out using SMART 59 PCR primer with an
automated sequencer (Applied Biosystems Inc, Foster City, CA,
USA) using standard protocols [21]. Data were analyzed with
PHRED [22] to identify and trim quality reads. Human
mitochondrial sequences were trimmed or eliminated using
Cross-match programs. All sequences have been deposited in
DNA Data Bank of Japan (accession numbers: HX784107–
HX787324).
EST sequences were assembled and clustered by the method
used by Ogura et al. [23] in which the gene-clustering method,
BLASTCLUST, was performed to obtain a rough estimation of
clusters containing similar sequences. The Phragment Assembly
Program (PHRAP) was used to assemble the sequence in the
estimated clusters. Functional annotation was conducted on the
nonredundant data set of human ERM ESTs. Gene ontology
(FatiGO) was used to categorize human eye ESTs with respect to
Kyoto Encyclopedia of Genes and Genomes (KEGG) biological
pathways [24].
To identify library-specific genes that were differentially
expressed in PVR-ERM and secondary ERM, we used the
method described in Susko and Roger [25] based on Binomial and
Chi-square tests for the expression frequencies patterns in which
genes occur in each library.
Enzyme-linked immunosorbent assay (ELISA) for sCD44
and sVCAM-1
The levels of both CD44 and VCAM1 in the vitreous fluid from
the same eye were measured with an enzyme-linked immunosor-
bent assay (ELISA) for human sCD44 (Gen-Probe, San Diego,
USA) and sVCAM-1 (RayBiotech; Norcross, GA). Each assay was
performed according to the manufacturer’s protocols as explained
in detail in our publication [26]. The levels of sCD44 and
sVCAM-1 in the vitreous fluid were within the detection range of
the respective assays; the minimum detectable concentration was
0.113 ng/mL for sCD44 and 0.3 ng/mL for sVCAM-1. The
intra-assay coefficient of variation [CV] was 1.52% and the inter-
assay CV was 3.08% for sCD44, 10% and 12% for sVCAM-1.
Statistical Analyses
Statistical analyses were performed using JMP (version 7.0, SAS
Institute, Cary, NC), a commercial statistical software package.
The distribution of the data was first determined by the Shapiro-
Wilk tests. The significance of the differences in the sCD44 and
sVCAM-1 levels between the different groups was determined
with the Mann-Whitney test. The correlation between the levels of
sCD44 and sVCAM-1 was determined by the Spearman
coefficient of correlation.
Results
Construction of human ERM cDNA libraries and EST
analysis
We constructed a cDNA library from resected PVR-ERMs and
secondary ERMs with SMART technology. Agarose gel electro-
phoresis of amplified PCR isolates had a smear band that
extended from 0.1 kb to .4 kb (data not shown). We performed
2688 single-pass sequence analysis from the 59end of the individual
clones from the PVR-ERMs and on 1632 secondary ERMs cDNA
library (Table 1). Of these 2688 and 1632 clones, 323 and 237
clones, respectively, were of low quality or were repetitive
sequences and were deleted from further analysis. Through the
EST assembly system, 2365 high-quality ESTs from PVR-ERMs
were clustered 1395 high-quality ESTs from secondary ERMs
were clustered and assembled to 799 nonredundant clusters
representing individual genes.
We next performed sequence similarity searches to compare
every EST to those in public databases. For ESTs with known
gene matches in public databases, functional annotations were
retrieved from the Ensembl database and analyzed by FatiGo.
Among the 1116 nonredundant cluster derived from the PVR-
ERM library, 916 (82%) matched the human cDNA database
(Ensembl). The remaining 200 (18%) corresponded to potentially
new ESTs or untranslated sequences. Among the database-
matched, 916 clusters were subdivided to functional subsets of
genes related to metabolism, cell adhesion, cytoskeleton, signaling,
and other functions by FatiGo analysis (Figure 1A). Among these,
metastasis associated lung adenocarcinoma transcript 1 (MALAT1)
and fibronectin precursor (FN1) appeared to be the most abundant
transcripts in the PVR-ERMs (Table 2). All non-redundant sets of
ESTs expressed in PVR-ERMs are shown in the Table S1.
Among the 799 nonredundant clusters derived from the
secondary ERM libraries, 637 (80%) matched the human cDNA
database (Ensembl). The remaining 162 (20%) corresponded to
new ESTs or untranslated sequences. Among the database-
matched 799 clusters, 637 were subdivided by functional subsets
of genes related to metabolism, signaling, ribosome, cytoskeleton,
and other functions by FatiGo analysis (Figure 1B). Among these,
Zinc finger protein 713 (ZNF713) and forkhead box K1 (FOXK1)
were the most abundant transcripts in the secondary ERM (Table
3). All non-redundant sets of ESTs expressed in secondary ERMs
are shown in the Table S2. Approximately one-third of the ESTs
were common to PVR-ERMs and secondary ERMs. All sequences
have been deposited in DNA Data Bank of Japan.
We then determined the genes that were differentially expressed
in the PVR-ERMs and secondary ERMs using the approaches
proposed by Susko and Roger [25]. Based on their methods, four
genes, MALAT1, ZNF713, FN1, and PARP8,were abundantly
represented (P-value,B-H cutoff) in the two libraries were
identified. The data also showed that 52 genes were highly
represented in either PVR-ERMs or secondary ERMs (P-
value,0.1). Twenty-three genes were expressed at higher levels
in the PVR-ERMs and 29 genes were expressed at higher levels in
secondary ERMs (Table 4).
The genes highly expressed in PVR-ERMs were subdivided by
functional subsets of those related to cell adhesion, proliferation,
and other functions. In contrast, the genes related to ribosomes,
metabolism, and signaling were preferentially up-regulated in
secondary ERMs (Table 4).
In Silico gene/protein network analysis
To identify potential biological relationships among the genes
expressed in the ERMs, we used the recently developed Search
Tool for the Retrieval of Interacting Genes (STRING) 9.0
database (http://string-db.org). STRING is a web-based software
that can extract protein-protein interactions that include direct
(physical) and indirect (functional) associations [27]. We queried
the gene symbols of 916 and 637 genes from the PVR-ERM and
secondary ERM cDNA libraries, respectively, against STRING
and obtained predicted interactions for genes/proteins. Of the 916
genes submitted to the PVR-ERM cDNA library, 843 (92.0%)
yielded 4274 possible physical relationships to other genes/
Genes Highly Expressed in PVR
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proteins which included 3358 proteins that had not been detected
in the PVR-ERM library (Table S3).
Of the 637 genes submitted to the secondary ERM cDNA
library, 561 (88.0%) yielded 3270 possible physical relationships to
other genes/proteins which included 2633 proteins that were not
detected in the secondary ERM library (Table S4).
Genes related to cell adhesion are supposed to be characteristic
components of PVR-ERMs (Table 4). The gene symbols of 10 cell
adhesion-related genes, FN1, COL1A2, COL1A1, COL3A1, TIMP3,
LGALS1, THBS1, DCN, POSTN, SPARC, that were preferentially
expressed in the PVR-ERMs cDNA library, were queried against
the STRING database. This yielded 70 possible physical
relationships to other genes/proteins, which included an addition-
al 60 genes that were not detected in the PVR-ERM library
(Figure 2).
Enzyme-linked immunosorbent assay (ELISA) for In Silico
Extracted Proteins
To determine if these possibly related genes/proteins extracted
only from the public database in silico are indeed elevated in the
vitreous of patients with PVR, we chose CD44 and VCAM-1
(Figure 2, arrows) which were extracted as interacted nodes by
molecular network involved in cell adhesion-related genes detected
in the PVR-ERM library. We examined the concentration of these
two molecules, in 11 vitreous samples of patients with PVR
collected during vitrectomy, and in the 26 vitreous samples
obtained from patients with secondary ERM. The concentration
of both sCD44 and sVCAM-1 in the vitreous was significantly
higher in the patients with PVR (14.05 ng/mL, range, 6.89–
72.87 ng/mL; and 43.50 ng/mL, range, 8.04–247.35 ng/mL),
than in eyes with secondary ERM (4.26 ng/mL, range, 1.47–
12.06 ng/mL; and 9.15 ng/mL, range, 0–64.70 ng/mL; P,0.01;
Figure 3).
The correlation between the vitreous concentrations of sCD44
and sVCAM-1 was statistically significant (r = 0.971; P,0.0001;
Spearman correlation coefficient; Figure 4).
Discussion
We searched Medline with key words ‘‘epiretinal membrane’’
and ‘‘gene expression profiling’’, and did not find any papers
reporting a profile of the gene expression in human PVR-ERMs or
in secondary ERMs. The EST classification by BLAST suggested
that the ERMs, especially those associated with a PVR, result from
a complex pathological process with alterations in the expression
of a variety of functional genes. These genes play important roles
in the progression of PVR-ERMs.
The most highly expressed gene in the PVR-ERM was
MALAT1, a long, non-coding RNA that regulates the processing
pre-mRNAs in mammalian cells. It is associated with metastasis,
and it regulates cell motility through a concomitant regulation of
the expression of motility-related genes by transcriptional and/or
post-transcriptional regulation [28]. However, MALAT1 has not
been shown to be synthesized by PVR-ERMs. The strong
expression of MALAT1 in PVR-ERMs could be explained by
the need for extensive migration of PVR-ERMs on the retina.
The PVR process resembles an aberrant wound-healing
response in which several stages can be distinguished: attachment,
migration, and proliferation of cells; deposition and remodeling of
the extracellular matrix; and contraction [29–32]. Comparisons of
the gene expression profile of PVR-ERM to that of secondary
ERMs showed an increased expression of genes involved in cell
adhesion and proliferation in the PVR-ERMs (Table 4). This is
consistent with an aberrant wound-healing response.
Among the components of the extracellular matrix, type II
collagen, secreted protein acidic, cysteine-rich (SPARC), throm-
bospondin (THBS), and fibronectin (FN), are also major compo-
nents of the vitreous [33,34]. Indeed, FN is the second most
abundant transcript in the PVR-ERM library (Table 2). However,
our EST analyses demonstrated an increased expression of FN1,
COL1A2, COL1A1, COL3A1, TIMP3, LGALS1, THBS1, DCN,
POSTN, SPARC as cellular adhesion components (Table 4). This
suggests that cells that comprise the PVR-ERMs actively produce
a variety of cell adhesion-related molecules and act in an autocrine
fashion. These results are in good agreement with a morphological
study showing that the amount of extracellular matrix in ERMs
was positively correlated with the disease process, i.e., greater in
PVR than slowly progressive ERM [35].
Figure 1. Known human genes identified in the human epiretinal membrane (ERM) associated with PVR (A) and secondary ERM (B)
are grouped according to the KEGG functional categories.
doi:10.1371/journal.pone.0054191.g001
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We have recently demonstrated that periostin, a secreted
extracellular matrix (ECM) protein that is found in areas of
pathological fibrosis, may play significant roles in the development
of fibrovascular membranes (FVMs) associated with PDR [14].
The results of the present study showed that the POSTN is also
highly expressed in PVR-ERMs, and the periostin protein is
markedly increased in the vitreous of patients with PVR (Ishikawa
K and Yoshida S, manuscript in preparation) as is PDR. These
observations strongly support the idea that periostin is closely
involved in the proliferation of ERMs commonly associated with
both PDR and PVR. Whether periostin might serve as new
molecular target to inhibit epiretinal fibrous proliferation awaits
further studies.
Several genes related to proliferation, viz., MALAT1, SER-
PINE1, CD320, and STAT3, were up-regulated in PVR-ERMs.
These findings are in agreement with those obtained from
histological studies showing rapidly growing PVR-ERMs had the
highest density of cells and the largest number of anti-Ki-67
labeled cells [36–38]. Thus, proliferation is most likely a major
contributor to the rapid expansion of PVR-ERMs.
In comparison to the genes preferentially expressed in PVR-
ERM, genes preferentially expressed in the secondary ERMs were
related to ribosome and metabolism and might serve a
housekeeping role (Table 4). This suggests that many of the
actively expressed genes are housekeeping genes in secondary
ERMs, and the tissue is relatively more resting in comparison to
PVR-ERMs. This then indicates that the aforementioned genes
that are preferentially increased in PVR-ERM may represent an
aggressive phenotype of PVR thus may be attractive therapeutic
targets to inhibit the progression of PVR.
Although our approach obtained important information, there
is still one step that requires further study. Our current EST study
lacks depth of sequencing. To reinforce the relatively low
representation, we attempted to use a bioinformatic approach
with the STRING software [27]. Because analyzing tens of
thousands sequences is time-consuming and costly, we used in Silico
Figure 2. Molecular networks associated with the genes expressed in ERMs associated with PVR (PVR-ERM) are shown. Gene symbols
of 10 cell adhesion-related genes (FN1, COL1A2, COL1A1, COL3A1, TIMP3, LGALS1, THBS1, DCN, POSTN, SPARC) from the PVR-ERM cDNA library were
queried against the STRING database, and the predicted interactions for genes/proteins were obtained. Filled black circles represent the submitted 10
genes/proteins from the PVR-ERM cDNA library, and the white circles represent potentially expressed 60 genes in PVR-ERMs that are extracted in
Silico. Of these, CD44 and VCAM-1 were examine by ELISA and are shown by arrows. The gene names are shown next to the circles. The edges
connecting two circles represent the predicted functional associations. An edge is drawn with up to 7 differently colored lines. These lines represent
the presence of the seven types of evidence used in predicting the associations. A red line indicates the presence of fusion evidence; a green line-
neighborhood evidence; a blue line–co-occurrence evidence; a purple line-experimental evidence; a yellow line-textmining evidence; a light blue
line-database evidence; and a black line–co-expression evidence.
doi:10.1371/journal.pone.0054191.g002
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analyses which effectively uses the wealth of public databases to
develop a more comprehensive gene expression signature associ-
ated with PVR-ERMs. Although the database is biased toward
well-studied genes relative to newly discovered genes, it offers a
method for rapidly establishing potential associations between
genes and functional pathways (Figure 2). In support of this, we
were able to demonstrate that CD44 and VCAM-1, which were
extracted only from the public database in Silico are indeed
elevated in the vitreous of patients with PVR, and that there is a
strong correlation between the two molecules in the development
of ERMs (Figures 3 and 4). This is in parallel with our previous
study that showed that more than 90% of computationally
extracted biologically-related candidate genes were confirmed to
be expressed in FVMs [13], and may intensify the usefulness of the
bioinformatic approach to further extract important genes.
CD44, a cell-surface adhesion molecule and receptor for
hyaluronan, plays an important role in cell migration and tumor
growth and progression [39]. Additionally, it was recently shown
to be involved in the TNF-a-induced epithelial-mesenchymal
transition [40]. VCAM-1 may play a pathophysiologic role both in
immune responses and in leukocyte emigration to sites of
inflammation through interaction with VLA4 [41]. In spite of
the presumed functions of these two molecules, both sCD44 and
sVCAM-1 may play significant roles in the development of PVR,
but no direct evidence has yet been reported. Moreover, the up-
regulation and strong correlation of sCD44 and sVCAM-1 found
in the vitreous of patients with PVR indicates that these two
molecules are involved in the progression of PVR in a coordinated
manner. Therefore, further studies are required to determine the
role played by sCD44 and sVCAM-1 in the pathogenesis of PVR.
In summary, we have generated a profile of the gene expression
in human ERMs. Our study supports the previous hypothesis that
formation of PVR-ERMs, even from genomic points of view, is an
aberrant form of healing response. This consists of cellular
proliferation, migration, extracellular deposition, and contraction.
In combination with the bioinformatic approach, we were able to
obtain new evidence that such molecules as periostin and CD44
are possibly involved in the molecular pathways associated with
the formation of PVR. Further investigations of these newly
detected genes are needed to determine whether they can be new
targets for combating the development and progression of PVR-
ERMs.
Figure 3. sCD44 (A) and sVCAM-1 (B) concentrations in the vitreous fluid of patients with secondary ERM and proliferative
vitreoretinopathy patients (PVR-ERM). The levels of both sCD44 and sVCAM-1 were significantly higher in the patients with PVR than in the eyes
with secondary ERM (*P,0.001).
doi:10.1371/journal.pone.0054191.g003
Figure 4. Correlations of vitreous sCD44 and sVCAM-1 levels in
patients with PVR. There was a strong statistically significant
correlation between the vitreous concentration of sCD44 and sVCAM-
1 (r=0.971;P,0.0001).
doi:10.1371/journal.pone.0054191.g004
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Supporting Information
Table S1 The most abundantly represented genes in the
PVR-ERMs cDNA library. The bold letter shows that the
genes were expressed both the PVR-ERMs and Secondary ERMs.
(XLSX)
Table S2 The most abundantly represented genes in the
Secondary ERMs cDNA library. The bold letter shows that
the genes were expressed both the PVR-ERMs and Secondary
ERMs.
(XLSX)
Table S3 Possible physical interactors to the proteins
encoded by cDNAs expressed in the PVR-ERMs library.
(XLSX)
Table S4 Possible physical interactors to the proteins
encoded by cDNAs expressed in the Secondary ERMs
library.
(XLSX)
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